Sukgu Han, MD

Professor of Clinical Surgery and Neurological Surgery

Image of Sukgu Han, MD
Is this your profile? Click to edit

Overview

Dr. Han Is the Chief of the Division of Vascular Surgery and Endovascular Therapy. He also serves as a Co-director of Comprehensive Aortic Center at Keck Hospital of University of Southern California. He holds the title of Professor of Surgery at the Keck School of Medicine of USC.

Dr. Han completed his undergraduate education at the University of California, Irvine, where he graduated with magna cum laude honors in 2000. He obtained his M.D. from the University of California, Irvine School of Medicine, where he was awarded a membership of Alpha Omega Alpha honors society as a third-year medical student. He completed general surgery training at our own University of Southern California, where he was voted the most outstanding chief resident by the faculty in 2012. During residency, he also obtained a master’s degree in biomedical engineering at the Viterbi School of Engineering at USC. Dr. Han went on to complete vascular surgery fellowship training at the University of California, San Francisco. Dr. Han obtained additional dedicated training in complex aortic repairs at the Mayo Clinic in Rochester, MN.

Since joining USC as faculty in 2014, Dr. Han has been instrumental in advancing the Aortic Center at Keck Medical Center of USC as one of the most robust programs in the country for care of patients with aortic emergencies and complex aortic pathologies. Dr. Han also serves as a principal investigator on numerous clinical trials on cutting-edge branched, fenestrated endovascular aortic stent grafts. Dr. Han is a frequent invited lecturer on complex aortic repairs at both national and international meetings. He maintains one of the busiest clinical practices at USC.

Dr. Han is board certified in Vascular Surgery and General Surgery.

Publications

  • Midterm outcomes of off-the-shelf multibranched versus physician-modified endografts for endovascular repair of complex and thoracoabdominal aortic aneurysms: A systematic review and meta-analysis. J Vasc Surg. 2026 Aug; 84(2):259-275.e1.. View in PubMed
  • Long-term trends of quality of life in patients who undergo branched endovascular repair of pararenal and extent IV thoracoabdominal aortic aneurysms. J Vasc Surg. 2026 Aug; 84(2):321-330.e3.. View in PubMed
  • Immune checkpoint inhibitors are associated with peripheral artery disease in cancer patients. J Vasc Surg. 2026 Jun; 83(6):1637-1648.e6.. View in PubMed
  • Distal Extent of Aortic Dissection Increases Risk of Malperfusion Syndromes and Need for Reoperation in Patients with Acute Type B Aortic Dissection. Ann Vasc Surg. 2026 Jul; 128:298-309.. View in PubMed
  • Early Outcomes of Off-the-Shelf Thoracoabdominal Multibranch Endoprosthesis for Type IA Endoleak from Failed Infrarenal and Complex Endovascular Aortic Repairs. Ann Vasc Surg. 2026 Apr; 125:152-158.. View in PubMed
  • Benchmark Results for Physician-Modified Endografts. Ann Vasc Surg. 2026 Feb; 123:693-701.. View in PubMed
  • Complex Cervical Debranching During Thoracic and Arch Endovascular Aortic Repair is Associated with Increased Risks of Local Complications, Reintervention, and Mortality. Ann Vasc Surg. 2026 Mar; 124:83-92.. View in PubMed
  • Risk of lower extremity complications with GLP-1 receptor agonists, SGLT2 inhibitors, and DPP-4 inhibitors in peripheral artery disease. Diabetes Res Clin Pract. 2025 Dec; 230:112982.. View in PubMed
  • Utilization of Zenith Alpha Thoracic 2.0 to facilitate physician-modified triple retrograde inner branched endovascular repair of the aortic arch via a single percutaneous femoral access. J Vasc Surg Cases Innov Tech. 2026 Feb; 12(1):102017.. View in PubMed
  • Laser in situ fenestrated endograft (LIFE) repair of complex aortic arch pathology: Early outcomes from the multicenter LIFE registry. J Vasc Surg. 2026 03; 83(3):647-655.. View in PubMed